Purine Nucleoside/Nucleobase Transporters in Leishmania

利什曼原虫中的嘌呤核苷/核碱基转运蛋白

基本信息

  • 批准号:
    8056669
  • 负责人:
  • 金额:
    $ 38.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-03-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This project will probe the role of purine nucleoside and nucleobase transporters (NTs) in the biology of Leishmania parasites. All parasitic protozoa examined to date are unable to synthesize purines and must salvage these essential nutrients from their hosts. The first step in salvage is the uptake of purine nucleosides or nucleobases across the parasite plasma membrane by NTs. There are three Specific Aims. The first Specific Aim is to study the structure and function of a model nucleoside transporter from L. donovani, LdNT1.1, to elucidate how nucleoside transporters function in Leishmania and in other parasitic protozoa. The first component of this Specific Aim is to analyze 18 previously identified missense mutants of LdNT1.1 that are non-functional in transport or have altered substrate specificity. These mutants will be examined for those that are non-functional because they fail to bind substrate and those that are still able to bind substrate but unable to translocate it across the plasma membrane. These experiments will identify amino acids that play crucial roles in substrate recognition and binding or in substrate translocation and will thus define components of the permease that promote its two essential mechanistic functions. The second component of Specific Aim 1 is to define extracellular and intracellular gating residues for LdNT1.1, functionally important residues that interact to close off the permeation pore in the inward-facing and outward-facing orientation respectively. The second Specific Aim entails the creation of a structural model of LmaNT4, a unique nucleobase transporter from L. major that functions optimally at pH 5, the intracellular pH of the macrophage phagolysosome where the parasite resides in the mammalian host, and the genetic dissection of key residues that likely control this unusual pH optimum. The third Specific Aim is to examine the molecular mechanisms L. donovani employs to adapt to purine starvation. Preliminary evidence reveals that the LdNT2 protein is dramatically upregulated upon purine starvation whereas the level of its mRNA is unaffected. Planned experiments will determine whether this regulation operates at the level of translation, protein turnover, or both. The potential regulation of the other LdNTs by purine limitation will also be examined. PUBLIC HEALTH RELEVANCE: The overall objective of this proposal is to study in detail the structure, function, and regulation of purine nucleoside transporters in the parasite Leishmania donovani that causes the fatal disease visceral leishmaniasis. Uptake of purines is essential for Leishmania and all parasitic protozoa, underscoring the crucial role of purine nucleoside/nucleobase transporters in these microorganisms, and these transporters also mediate the uptake of several drugs or experimental drugs employed against Leishmania or other parasitic protozoa. The essential roles that purine nucleoside/nucleobase transporters play in parasite viability further suggests selective inhibition of these transporters could be exploited to develop novel drugs against parasitic diseases.
描述(由申请人提供):该项目将探测嘌呤核苷和核碱酶转运蛋白(NTS)在利什曼原虫寄生虫生物学中的作用。迄今为止,所有检查的寄生原生动物都无法合成嘌呤,必须从宿主那里挽救这些基本营养素。挽救的第一步是通过NTS摄取嘌呤核苷或核苷酶在寄生虫质膜上的摄取。有三个特定的目标。第一个具体目的是研究核苷转运蛋白的结构和功能,从L. donovani,ldnt1.1,以阐明核苷转运蛋白在利什曼尼亚和其他寄生虫原生动物中的功能。该特定目的的第一个组成部分是分析18个先前确定的LDNT1.1的错义突变体,这些突变体在运输方面非功能或底物特异性改变。这些突变体将对那些非功能性的突变体进行检查,因为它们无法结合底物,并且仍然能够结合底物但无法在质膜上易位的突变体。这些实验将确定在底物识别和结合或底物易位中起着至关重要的作用的氨基酸,从而定义了越过渗透酶的成分,从而促进其两种必不可少的机械功能。特定目标1的第二个组成部分是定义LDNT1.1的细胞外和细胞内门控残基,在功能上重要的残基分别相互作用,以关闭触及孔的渗透孔和向外方向的渗透孔。第二个特定目的需要创建LMANT4的结构模型,Lmant4是L. Major的独特核碱酶转运蛋白,该转运蛋白在pH 5处最佳起作用,pH 5,巨噬细胞吞噬体的细胞内pH值,寄生虫属于哺乳动物宿主中的巨噬细胞吞噬体,以及可能控制这种不寻常的pH Optimual PH Optimual ph。第三个具体目的是检查L. donovani使用的分子机制适应嘌呤饥饿。初步证据表明,LDNT2蛋白在嘌呤饥饿时显着上调,而其mRNA的水平不受影响。计划的实验将确定该调节是在翻译,蛋白质周转或两者兼而有之的水平。还将检查其他LDNT对其他LDNT的潜在调节。 公共卫生相关性:该提案的总体目的是详细研究寄生虫Donovani中嘌呤核苷转运蛋白的结构,功能和调节,从而导致致命性疾病内脏利什曼病。嘌呤的吸收对于利什曼原虫和所有寄生虫原生动物至关重要,强调了嘌呤核苷/核苷酶转运蛋白在这些微生物中的关键作用,这些转运蛋白还介导了对利什马尼亚或其他帕亚马尼亚质子原生素的几种药物或实验性药物的摄取。嘌呤核苷/核苷酶转运蛋白在寄生虫生存能力中起着的重要作用进一步表明,可以利用对这些转运蛋白的选择性抑制来开发针对寄生虫病的新药物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott M Landfear其他文献

Scott M Landfear的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott M Landfear', 18)}}的其他基金

Function and Trafficking of Flagellar Membrane Proteins in Leishmania mexicana
墨西哥利什曼原虫鞭毛膜蛋白的功能和运输
  • 批准号:
    10632896
  • 财政年份:
    2023
  • 资助金额:
    $ 38.12万
  • 项目类别:
Interdisciplinary Training in Microbial Pathogenesis and Immunology
微生物发病机制和免疫学跨学科培训
  • 批准号:
    10712455
  • 财政年份:
    2023
  • 资助金额:
    $ 38.12万
  • 项目类别:
The Neddylation Pathway in Leishmania donovani - A High Opportunity Target
杜氏利什曼原虫的 Neddylation 途径 - 高机会目标
  • 批准号:
    10349372
  • 财政年份:
    2021
  • 资助金额:
    $ 38.12万
  • 项目类别:
Development of Novel Natural Product Inspired Antileishmanial Drugs
受天然产物启发的新型抗利什曼药物的开发
  • 批准号:
    10225214
  • 财政年份:
    2021
  • 资助金额:
    $ 38.12万
  • 项目类别:
The Neddylation Pathway in Leishmania donovani - A High Opportunity Target
杜氏利什曼原虫的 Neddylation 途径 - 高机会目标
  • 批准号:
    10493446
  • 财政年份:
    2021
  • 资助金额:
    $ 38.12万
  • 项目类别:
Development of Novel Natural Product Inspired Antileishmanial Drugs
受天然产物启发的新型抗利什曼药物的开发
  • 批准号:
    10382455
  • 财政年份:
    2021
  • 资助金额:
    $ 38.12万
  • 项目类别:
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes
非洲锥虫血流中必需的 KHARON1 蛋白的功能
  • 批准号:
    9226017
  • 财政年份:
    2016
  • 资助金额:
    $ 38.12万
  • 项目类别:
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes
非洲锥虫血流中必需的 KHARON1 蛋白的功能
  • 批准号:
    9007963
  • 财政年份:
    2016
  • 资助金额:
    $ 38.12万
  • 项目类别:
Development of Drugs that Target the Malaria Hexose Transporter
开发针对疟疾己糖转运蛋白的药物
  • 批准号:
    8968767
  • 财政年份:
    2015
  • 资助金额:
    $ 38.12万
  • 项目类别:
Development of Drugs that Target the Malaria Hexose Transporter
开发针对疟疾己糖转运蛋白的药物
  • 批准号:
    9086222
  • 财政年份:
    2015
  • 资助金额:
    $ 38.12万
  • 项目类别:

相似国自然基金

妊娠期高血糖通过抑制AMPK活性导致胚胎神经元突起发育受损的作用和机制研究
  • 批准号:
    82001572
  • 批准年份:
    2020
  • 资助金额:
    16.0 万元
  • 项目类别:
    青年科学基金项目
CREBH通过调控SIRT3/脂肪酸氧化通路酶对非酒精性脂肪性肝病的影响及机制
  • 批准号:
    81900520
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
腺苷酸琥珀酸合成酶样1(Adssl1)通过影响嘌呤核苷酸代谢调控褐色脂肪活性的作用研究
  • 批准号:
    81974116
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
RNA甲基化(m6A)甲基转移酶VIRMA通过调控Rassf5表达影响植入后胚胎发育的机制研究
  • 批准号:
    31900604
  • 批准年份:
    2019
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
大肠埃希菌PNPase调控cAMP受体蛋白影响持留菌形成的机制研究
  • 批准号:
    81902110
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Deciphering a novel kinase function for adck2 in the heart
破译心脏中 adck2 的新激酶功能
  • 批准号:
    10664070
  • 财政年份:
    2023
  • 资助金额:
    $ 38.12万
  • 项目类别:
PARP1 and PARylation as novel effectors of gut inflammation
PARP1 和 PARylation 作为肠道炎症的新型效应物
  • 批准号:
    10679646
  • 财政年份:
    2023
  • 资助金额:
    $ 38.12万
  • 项目类别:
Unanticipated roles of C5aR1 Signaling Leading from Acute to Chronic Kidney Disease
C5aR1 信号转导从急性肾病到慢性肾病的意外作用
  • 批准号:
    10591053
  • 财政年份:
    2023
  • 资助金额:
    $ 38.12万
  • 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
  • 批准号:
    10661806
  • 财政年份:
    2022
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cancer Classifiers Based on RNA Sensors in Living Cells
基于活细胞中 RNA 传感器的癌症分类器
  • 批准号:
    10570559
  • 财政年份:
    2022
  • 资助金额:
    $ 38.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了